Skip to main content
PLOS One logoLink to PLOS One
. 2021 Oct 14;16(10):e0258495. doi: 10.1371/journal.pone.0258495

Making a science out of preanalytics: An analytical method to determine optimal tissue fixation in real-time

Daniel R Bauer 1,*, Torsten Leibold 2, David R Chafin 1
Editor: Anna Sapino3
PMCID: PMC8516200  PMID: 34648597

Abstract

Modern histopathology is built on the cornerstone principle of tissue fixation, however there are currently no analytical methods of detecting fixation and as a result, in clinical practice fixation is highly variable and a persistent source of error. We have previously shown that immersion in cold formalin followed by heated formalin is beneficial for preservation of histomorphology and have combined two-temperature fixation with ultra-sensitive acoustic monitoring technology that can actively detect formalin diffusing into a tissue. Here we expand on our previous work by developing a predictive statistical model to determine when a tissue is properly diffused based on the real-time acoustic signal. We trained the model based on the morphology and characteristic diffusion curves of 30 tonsil cores. To test our model, a set of 87 different tonsil samples were fixed with four different protocols: dynamic fixation according to our predictive algorithm (C/H:Dynamic, N = 18), gold-standard 24 hour room temperature (RT:24hr, N = 24), 6 hours in cold formalin followed by 1 hour in heated formalin (C/H:6+1, N = 21), and 2 hours in cold formalin followed by 1 hour in heated formalin (C/H:2+1, N = 24). Digital pathology analysis revealed that the C/H:Dynamic samples had FOXP3 staining that was spatially uniform and statistically equivalent to RT:24hr and C/H:6+1 fixation protocols. For comparison, the intentionally underfixed C/H:2+1 samples had significantly suppressed FOXP3 staining (p<0.002). Furthermore, our dynamic fixation protocol produced bcl-2 staining concordant with standard fixation techniques. The dynamically fixed samples were on average only submerged in cold formalin for 4.2 hours, representing a significant workflow improvement. We have successfully demonstrated a first-of-its-kind analytical method to assess the quality of fixation in real-time and have confirmed its performance with quantitative analysis of downstream staining. This innovative technology could be used to ensure high-quality and standardized staining as part of an expedited and fully documented preanalytical workflow.

Introduction

Clinical tissue processing techniques “fix” tissues with crosslinking agents that shut down metabolism within cells and preserve crisp and clear cellular morphology. The most prevalent fixative is 10% neutral buffered formalin (NBF) which is an aqueous solution of formaldehyde in a buffer and has been used for over a century [1]. Currently, proper fixation protocols are empirically determined by examining the histologically stained tissue for proper morphological features. There have been some published guidelines from the College of American Pathologists to provide better tissue handling standards, including suggested times of fixation for most tissues in room temperature formalin [2]. The result is a mixed bag of adequate and poor morphology depending on the operator, institution, tissue type, and biomarker of interest. Furthermore, by the time the morphology is interrogated, it is too late to improve the quality of the tissue so proper fixation the first time is critically important.

Tissue fixation is a time consuming process usually taking several hours to days depending on the type and size of the tissue. As pressures mount to decrease the turnaround time for patient care, rapid fixation protocols are being introduced. One such technology already being employed is to raise the temperature of the fixative to increase the crosslinking rate [321]. While this is practically effective, the use of increased fixative temperature has led to many reports of unsatisfactory tissue morphology based on hematoxylin and eosin (H&E) stain and variability in other molecular analysis, such as routine immunohistochemical (IHC) stains [2224]. Biologically, the use of heated fixative serves to crosslink proteins on the outside of the tissue sample while compromising the structure of proteins in the middle where sufficient fixative has not penetrated. A more promising rapid method that produces superior tissue fixation uses 10% NBF in two-temperature zones (cold+hot) [25, 26]. The cold step allows proper diffusion of formaldehyde into the tissue interior followed by a short heated phase that rapidly forms formaldehyde-based crosslinks.

Presently there are no established methods of actively monitoring either the diffusion of formaldehyde into tissues or the actual formation of crosslinks. Inadequately diffused tissues will only crosslink and fix where the fixative has penetrated, forming an outer ring of well-fixed tissue. Inadequate fixation is a leading cause of reported errors in anatomical pathology laboratories [2732]. Because current tissue fixation protocols lack real-time monitoring there is no way to guarantee sufficient formaldehyde concentrations in the tissue or conversely to know if a sample has become overfixed, which also has detrimental effects on stain quality [10, 33]. In short, current fixation techniques offer no quality assurance or tracking capability to tissue processing laboratories. This means when samples are improperly fixed expensive rework is required, if another sample is capable of being procured again at all. Although several methods for statically detecting diffusion exist including optical, ultrasound, and MRI, these detection mechanisms have not been implemented for tissue processing to better preserve cancer indicators [3438]. Some researchers have soaked tissues in radioactive formaldehyde and measured fluid penetration after exposure to photographic film as a measure of diffusion rates [39]. However, very little radioactivity is actually incorporated into the tissue and long exposure times led to fuzzy and unreliable results. Others have used ultrasound monitoring to look at crosslinking by comparing samples of unfixed to fixed tissues [4045]. Ultimately, neither of these techniques allows for monitoring in real-time when changes could be implemented to guarantee excellent tissue fixation and proper functional staining.

Therefore, to ensure sufficient formaldehyde was present throughout a tissue to guarantee proper staining, we developed a dynamic method to optimize tissue fixation using real-time detection of formalin diffusion. We have previously described an automated system that can detect penetration of a fixative into a raw biological tissue using acoustic time-of-flight (TOF) technology that exploits the discrete sound velocities of interstitial fluid and formalin [46]. As formalin diffuses into a tissue specimen and replaces exchangeable fluid (e.g. interstitial fluids), the overall composition of the tissue is physically altered resulting in a TOF differential. As faster formalin diffuses into the sample the tissue’s net sound velocity increases resulting in a monotonic decrease to the TOF signal. However, in our previous work the functional relationship between TOF-based diffusion signals and stain quality remained elusive. In this work, we report the development of a real-time statistical model and custom-modified tissue processor system that determines when a sample is adequately diffused enough to produce high-quality staining from downstream IHC assays.

Methods

Tissue acquisition and fixation

Human tonsil tissue was obtained fresh and unfixed from a local Tucson, Arizona hospital under an approved contractual agreement for procurement of biological samples. In accordance with approved protocol, all tissue samples were completely de-identified, if applicable, and anonymized so there was no possibility that anyone could link the specimen back to a patient. Furthermore, in accordance with protocol, all tissue samples were collected under the requirement that the tissue was medical waste material (i.e. leftover diagnostic specimens) such that no informed consent was required. All data was analyzed anonymously. Because all biological specimen were fully anonymized tissue that was medical waste material, no internal ethics review committee or IRB was required for these studies. Whole tonsils from same day surgeries were transported to Roche Tissue Diagnostics on wet ice in biohazard bags. Samples of tonsil tissues of precise sizes were obtained by using 6 mm diameter biopsy punch (Miltex #33–36). For fixation experiments from a single organ, four 6 mm cores were obtained from the same whole unfixed tonsil organ. One core was used as a positive fixation control and was placed into room temperature NBF for 24 hours (RT, N = 24). One core was used as a positive fixation control for cold+hot fixation, and was placed for 6 hours into 10% NBF (Saturated aqueous formaldehyde from Fisher Scientific, Houston, Texas, buffered to pH 6.8–7.2 with 100 mM phosphate buffer) previously chilled to 4°. This control core was removed and placed into 45°C NBF for an additional 1 hour to initiate crosslinking (6+1, N = 24). One core was used as an intentionally underfixed control for cold+hot fixation, and was placed for 2 hours into 10% NBF for previously chilled to 4°. This underfixed control core was removed and placed into 45°C NBF for an additional 1 hour to initiate crosslinking (2+1, N = 21). One core was secured in a tissue cassette and placed in between the TOF sensors on the automated fixation device and the algorithm and tissue processor monitored the status of diffusion (Dynamic, N = 18). After fixation, all samples were processed in a commercial tissue processor set to an overnight cycle and embedded into wax.

Time-of-flight measurement

As previously described, we developed a digital acoustic interferometry algorithm that calculated TOF differentials with subnanosecond precision [46]. Briefly, pairs of 4 MHz focused transducers were spatially aligned and tissue samples were placed at their common foci. One transducer was programmed to send out a sinusoidal pulse that was detected by an accompanying transducer after traversing the formalin and tissue and the received pulse was used to calculate the transit time. An initial calibration TOF reading was acquired by measuring the signal through only formalin. That baseline reading was subtracted from the TOF with the tissue present to isolate the phase alteration from the tissue. This detection method simultaneously isolated the acoustic TOF shift due to diffusion and compensated for environmentally-induced fluctuations in the formalin. For each tissue, TOF measurements were recorded every 1 mm along the vertical axis of the tissue, with typically 5–9 total measurements per tissue depending on the size of the biospecimen. All of the TOF signals for a given tissue were then averaged together and the spatially-averaged signal was recorded as representative of the tissue’s overall rate of formalin diffusion. In practice, the form of the TOF diffusion signal from multiple tissue types was well-correlated with a single-exponential decay function [47].

Histology

Paraffin tissue blocks were sectioned to 4 μm thick and placed onto Fisherbrand Superfrost Plus microscope slides (Thermo Fisher Scientific). One section was stained with H&E on a Ventana Medical Systems HE600 automated staining system to evaluate tissue morphology. In addition to the H&E slide, two serial sections were cut and stained with anti-FOXP3 (SP33) and anti-bcl-2 (SP66) with Di-aminobenzidine (DAB) for evaluation of stain intensity and coverage. For each stain, staining was performed according to the manufacturer’s protocol on a Ventana Benchmark Ultra XT automated staining system.

Statistical methods

The statistical model used to calculate in real-time when the TOF signal was representative of the tissue’s actual diffusion rate was initially developed using custom developed code written in MATLAB (Mathworks) using multiple functions from the Statistics and Machine Learning toolbox. When the final model was translated to the laboratory for implementation on our TOF-scanning hardware, it was translated into Python using several libraries including numpy, matplotlib, scipy, and kapteyn. To evaluate the data from different fixation methods, a Welch’s 2-sided t-test with a cutoff for statistical significance of p<0.002 was used.

Imaging and image processing

Each slide was imaged on a whole slide scanner (VENTANA iScan HT slide scanner) at 20X magnification with DAB stain and a hematoxylin counterstain. A custom developed software package written in MATLAB was used to analyze the images. A segmentation algorithm differentiated the entire tissue section from the background. A separate algorithm identified regions within the tissue footprint that comprised non-staining tissues (e.g. holes, cracks, stroma), to yield the most representative statistics around percent of tissue staining. The transmission images were log transformed and spectrally unmixed to isolate the DAB staining from the hematoxylin counterstain. The unmixed DAB concentration mappings were used to determine which pixels were DAB positive using a global threshold. Raw DAB concentrations were also recorded so the intensity of DAB staining could be analyzed. To study the effects of improper fixation, an algorithm was written that calculated the Euclidean distance to the nearest edge pixel so that intensity of DAB stain and DAB positivity could be studied for different fixation protocols.

Results

Criterion for real-time prediction of stain quality

To construct a model that could predict optimal fixation quality in real-time, we needed to understand the relationship between formalin diffusion and morphological properties. Diffusion is controlled mainly by concentration gradients and time according to Fick’s Laws of diffusion. Time course experiments (1.5, 3 and 6 hours) were performed using 6 mm cores of human tonsil tissues submerged into 4°C NBF followed by 1 hour in 45°C NBF [45]. After repeating the time course for 10 tonsil organs a minimum of 3 hours of cold NBF (C/H:3+1) was determined to produce acceptable histomorphology. Tissue morphology was improved with 5 hours in cold NBF (C/H:5+1) but further cold soak times provided no additional benefit. An additional 10 tonsil cores were then examined to confirm that a C/H:5+1 protocol produced high-quality staining, see cumulative results in Fig 1a.

Fig 1. Correlating NBF diffusion times with stain quality.

Fig 1

a) H&E images acquired with different cold soak times in NBF. Based on H&E based morphology, cold soak times of 1.5 hours, 3 hours, and 5 hours produced severely compromised, borderline, and exemplary staining, respectively. b) Example depiction of TOF diffusion curve with active NBF diffusion immediately after submerging tissue in NBF, manifesting with a rapidly changing TOF signal. Conversely, after several hours the tissue’s rate of diffusion had significantly slowed as the tissue and NBF approached osmotic equilibrium.

In the previous section, the diffusion times required to produce high-quality H&E staining were empirically determined. Next, we quantitatively characterized the diffusivity properties of human tonsil tissues to develop an analytical metric to determine when a sample was properly diffused. Several whole tonsil tissues were cored to 6 mm in diameter. A total of 38 6 mm tonsil samples were measured in cold (7±0.5°C) 10% NBF. Of the 38 samples, 14 were monitored for 3 hours and the remaining 24 samples were monitored for 5 hours. For each sample the diffusion was measured throughout the sample (1 mm intervals) and the spatially-averaged TOF curves were calculated. The characteristic TOF-based diffusion signals were highly correlated with a single-exponential curve of the form,

TOFt=Aavgetτavg+C (1)

where C is a constant offset in nanoseconds, Aavg is the amplitude of the exponential decay in nanoseconds, and τavg is the tissue’s average decay constant in hours. Samples scanned for 3 hours and 5 hours had average decay constants of 2.33 hours and 2.72 hours, respectively. The difference of 0.39 hours was statistically insignificant, indicating that the two datasets faithfully measured the same physical phenomena. This established that the TOF measurement system produced consistent and reproducible results for long and short diffusion times.

Having validated the diffusion monitoring system, the dataset of 38 6 mm tonsil samples was analyzed to find a correlation between the diffusive properties of each tissue and the empirically determined diffusion times required to produce ideal downstream staining. Numerous analytic techniques were employed including multivariate analysis, cluster based algorithms, characterization of the signal’s derivative, and principal component analysis. A slope based analysis, physically representing the rate of diffusion, was found to provide ideal and meaningful discrimination of samples that were in cold formalin for 3 hours (i.e. adequately staining) versus 5 hours (i.e. ideally staining throughout the sample). To significantly mitigate noise and more accurately represent the active rate of diffusion, the derivative of the TOF signal was calculated based on a fit to a single exponential function. Additionally, ideal discrimination of the two datasets was achieved by amplitude-normalizing each signal,

mt=to=1001τavgetoτavg%hr (2)

where m is the derivative of the amplitude-normalized TOF signal at time to and the brackets denote the slope’s units of percent TOF change per hour of diffusion. Fig 2a displays the normalized slope, at 3 hours and 5 hours respectively, of each sample. The average rate of diffusion at 3 hours was -11.3%/hr, whereas at 5 hours the rate of diffusion had significantly slowed to -5.3%/hr, with several samples approaching full osmotic equilibrium as indicated by a near zero rate of diffusion. The different distributions of normalized rates of diffusion at 3 hours and 5 hours were highly statistically significant (p<2e-15), indicating a drastic and physically real difference in the rate of diffusion at 3 hours versus 5 hours. Similarly, we observed a difference in H&E-based morphology for samples with cold diffusion times of 3 hours and 5 hours. We conclude that the TOF-based diffusion metric has sufficient capability and sensitivity to discriminate between poorly fixed (i.e. 3 hours of NBF diffusion) and well-fixed (i.e. 5 hours of NBF diffusion) tissue samples. The correlation between TOF-based diffusion metrics and H&E-based stain quality, indicates our diffusion monitoring system, if properly calibrated, was fundamentally capable of predicting eventual stain quality. Given this validation, Eq. 2 was solved for the time required to reach a criterion rate of NBF diffusion,

tdonem~=-τavglnm~thresτavg, (3)

where tdone is the time required to reach a threshold slope (mthresh), and the |…| symbol indicates the absolute value. For a given tissue specific decay constant and normalized rate of diffusion, this equation can be used to calculate how long a sample needs to be in cold formalin before it will reach a threshold rate of diffusion. To evaluate rate of diffusion as a stain quality predictor, three threshold slope values (mthres = -7.4%/hr, -8.0%/hr, -10.4%/hr) were chosen for evaluation, as displayed visually in Fig 2a. Note that large absolute slope values represent more fluid exchange per hour. Thus as a sample’s active diffusion slows, the rate of diffusion will approach osmotic equilibrium (i.e. 0%/hr). Therefore, a larger threshold slope criterion predicts samples have adequate formaldehyde sooner. This is illustrated graphically in Fig 2b on a representative 6 mm piece of human tonsil, where decreasing diffusion rates translate to longer completion times.

Fig 2. Tuning rate of diffusion metric to predict stain quality.

Fig 2

a) Normalized slope for tonsil tissues at 3 hours (N = 14) and 5 hours (N = 24) in cold NBF when tissues are expected to have borderline and ideal staining, respectively. Different threshold diffusion rates of -7.4%/hr, -8.0%/hr, and -10.4%/hr are indicated with 3, 2, and 1 respectively. b) Average TOF signal from a 6 mm tonsil with the approximate locations of the threshold diffusion rates indicated. c-e) Plots of the projected completion times for each of the three evaluated threshold diffusion rates.

Additionally, the projected completion times for tissues in each dataset (3 hours and 5 hours) are displayed in Fig 2c-2e) as calculated from Eq. 2. For example, Fig 2c displays the projected completion times for the largest threshold slope of -10.4%/hr. This slope criterion predicted an average completion time of 3.27 hours. However, 6 of the sample’s (16%) projected completion times are less than 3 hours and from our previous histological staining results, these samples are known to not be adequately diffused throughout. Additionally, one sample would be misidentified with this slope criterion. Based on these findings all samples must not have sufficient formalin to stain acceptably when their rate of diffusion is -10.4%/hr. The middle threshold slope value of -8.0%/hr produces ideal discrimination between the two datasets and reasonable completion times between 3 and 5 hours. However, to be as conservative as possible, the lowest threshold slope value of -7.4%/hr was selected as the criterion for when samples will stain ideally throughout. With this metric, 6 mm tonsil cores were projected to take between 3.21 hours and 4.96 hours, which we know from downstream histological staining to be reasonable. Based on these experiments and analysis, once a sample’s real-time rate of normalized diffusion slows to,

m˜thres(t)7.4%/hr, (4)

the sample will have sufficient formalin throughout to guarantee ideal and uniform histological staining.

Statistical model for real-time validation of TOF

Signal

A practical embodiment of the TOF technology requires the diffusion curve to be analyzed with temporally sparse data in the absence of a ground truth assessment of the tissue’s true temporal diffusion profile. For instance, the prediction of when a sample is optimally fixed is based on the detected rate of NBF diffusion at a given time. However, this prediction is only valid if the exponential fit of the tissue’s diffusion curve is representative of the tissue’s actual rate of diffusion. In particular at the beginning of an experiment when data is sparse, the detected rate of diffusion can change significantly due to a variety of sources (e.g. tissue deformation, thermal noise, fluidic variables, etc.) in addition to noise inherent to the TOF calculation. To overcome these limitations, we developed a statistical model to validate when the TOF curve had converged to the true diffusion profile of the tissue and was therefore accurate enough to make a prediction as to whether the sample was adequately fixed.

The developed solution was a statistical model that had three independent components that query different components of the TOF signal. All three components were continually re-calculated as TOF data points were calculated during cold NBF diffusion. When all three statistical parameters were simultaneously satisfied, the diffusion profile was judged to be accurate.

Condition #1 (Past Algorithm): This condition established that the current TOF fit was consistent with previously collected data. The decay constant of the single exponential line must have converged, as defined by 10 consecutive decay constants having less than a 2% difference relative to the average of the previous 6 decay constants.

Condition #2 (Present Algorithm): This condition established the statistical confidence of the presently collected data. The 95% percent confidence interval of the most recent decay constant must be below 0.7 hours.

Condition #3 (Future Algorithm): This condition established that there was sufficient statistical confidence to predict future TOF values. The 95% confidence interval of the TOF signal across all times (past, present, and future) must be below 2 ns.

Once all three statistical conditions were satisfied, the algorithm validated that the TOF signal from the tissue was representative of the actual rate of diffusion and predicted at what time the tissue will be properly fixed according to Eq. 2 with the threshold condition described in Eq 3. A graphical depiction of the real-time statistical model is displayed in Fig 3a where the TOF diffusion signal was judged representative at 3.08 hours, at which point the predictive algorithm calculated the tissue would be properly diffused at 4.47 hours. The calculation of the past, present, and future algorithms, up to the point they were satisfied, is plotted in Fig 3b)-3d), respectively. Additionally, a video of the model operating on data in real-time from a 6 mm piece of tonsil tissue is presented as supplemental data (S1 Video).

Fig 3. Example of statistical model to validate TOF diffusion signal.

Fig 3

a) TOF diffusion curve demonstrating how the validation algorithm works during real-time data acquisition. As data is collected, three statistical algorithms continually monitor the fidelity of the signal focusing on past, present, and future aspects of the data. Time to satisfy each algorithm is labeled on the plot with solid horizontal lines in order of convergence time. Once all three conditions of data fidelity are satisfied, the data is representative of the tissue’s actual rate of diffusion and the required diffusion time of the tissue was calculated. Detailed views of the present, future, and past algorithms are shown in Fig 4 b), c), and d) respectively. e) Plot of time to validate diffusion signal versus predicted fixation times for 105 tissues from 16 distinct organs. On average (blue star), 2.04 hours was required for the detected diffusion profile to converge onto the tissue’s actual rate of diffusion and tissues were predicted to need 2.96 hours of diffusion in cold formalin.

The overall efficacy of the methodology was tested on 105 previously collected TOF curves [47] from 16 different tissue types (Brain, Breast, Cervix, Colon, Duodenum, Lung, Gallbladder, Jejunum, Kidney, Liver, Lymph Node, Prostate, Skin, Testis, Tonsil, Uterine). Additionally, for breast, colon, liver and testis tissue the model was tested and validated on healthy and cancerous tissue. A simulation was written in which this a priori data was analyzed by the statistical model to simulate how it would behave on real-life empirical data. At the time the model validated the signal, the predicted time of optimal fixation was calculated to be within 27 minutes of the true time, as calculated by the fit at the end of the experiment. The statistical confidence of the decay constant at the time of convergence was ±7 minutes. These results confirm that the model determined in real-time when the TOF signal was representative of the tissue’s actual rate of diffusion and that predictions based on that data were accurate. Fig 3e) plots the time to validate characteristic diffusion curves versus the predicted fixation times. On average, the model converged to a valid fit 55 minutes before the sample was properly diffused. These results detail how the model was capable of determining when biospecimens will be ideally diffused nearly an hour before they were, and thus established the feasibility of a commercial embodiment of TOF-based diffusion monitoring coupled with a real-time assessment of fixation quality.

Validation of fixation predictive model with IHC

Staining

To confirm that the developed predictive model was truly predictive of eventual stain quality, we developed digital pathology tools to objectively and repeatably evaluate the level of staining of each slide. Digital analysis was performed on IHC slides with DAB staining a single marker and hematoxylin counterstain. A whole slide scan of each slide was acquired. The software segmented the tissue, and identified and removed areas that did not stain, such as connective tissue and stroma. For all regions with active staining, the software quantified the percent of the tissue that was DAB positive. Additionally, it calculated the edge distance, defined as the shortest possible distance to the border of the tissue sample. Next radial concentric 0.33 mm “zones” of the tissue were calculated so staining could be analyzed in regions with roughly equal concentrations of formalin. This geometrical representation of the tissue enabled the effects of improper fixation to be explicitly analyzed because formalin diffuses into a tissue from the periphery resulting in progressively less staining at the core of the tissue. A histogram was calculated plotting the percent of the tissue staining versus distance to the nearest tissue edge. Finally, we analyzed each radial zone of the tissue for proper staining by defining suppressed staining as DAB positivity less than half of the edge/maximum positivity. A graphical depiction of the image analysis workflow is presented in Fig 4.

Fig 4. Schematic of radial image analysis workflow used to analyze the impact of formalin diffusion on functional IHC staining to FOXP3.

Fig 4

To confirm that our developed metrology could accurately ascertain in real-time when a tissue was optimally diffused, we performed a large scale study with 87 distinct tonsil cores differentially fixed with one of four fixation protocols. For all fixation protocols, after fixation tissues were processed in a standardized fashion, embedded in paraffin blocks, and slides were cut and stained with DAB for FOXP3 and bcl-2 (see supplemental data). The first three fixation protocols were: cold NBF for 2 hours followed by heated NBF for 1 hour (C/H: 2+1, N = 24), cold NBF for 6 hours followed by heated NBF for 1 hour (C/H: 6+1, N = 21), and room temperature NBF fixation for 24 hours (RT:24hr, N = 24). Finally, we tested our real-time fixation prediction algorithm using the cold+hot fixation method in which tonsils were placed in cold NBF until our system determined they were sufficiently diffused at which point they were moved to heated formalin for 1 hour to initiate crosslinking (C/H:Dynamic, N = 18). In this experiment, the C/H:6+1 and RT:24hr protocols represented internal controls because these fixation methods were known to produce high-quality staining. Alternatively, the C/H:2+1 samples represented intentionally underfixed tissues. Representative images of the staining patterns for each fixation method are displayed in Fig 5. The two standard fixation protocols produced tissue that stained nearly uniformly whereas the C/H:2+1 tissue had significantly suppressed staining at the center of the tissue. Importantly, the tissue from the C/H:Dynamic protocol produced uniform FOXP3 staining consistent with the two gold-standard fixation protocols.

Fig 5. Example staining results for different fixation protocols.

Fig 5

Left column) Brightfield whole slide scan of tissue. Middle-left column) Heatmap of FOXP3 positivity for each tissue. Middle-right column) Graphical depiction of radial zones within each tissue indicating regions of deficient and proper staining, as defined by DAB positivity within 50% of the edge value. Right column) Histogram of FOXP3 staining versus distance to the edge of the tissue.

Furthermore, cumulative box and whisker plots for the entire 87 tissue study for FOXP3 staining are presented in Fig 6. The stain penetration depth, as defined by the distance at which staining drops to half its edge value, is plotted in Fig 6a and the area of the tissue that properly stained is plotted in Fig 6b. For both metrics the C/H:2+1 samples exhibited significantly reduced staining compared to the other three fixation methods (p<0.002). Importantly, C/H:Dynamic samples displayed staining results that were concordant with both the RT:24hr samples as well as C/H:6+1 samples. Additionally, dynamically fixed samples were in cold NBF for only 4.2 hours, meaning the TOF predictive algorithm produced tissues that stained as well as traditionally fixed tissues but several hours faster. Additionally, the average spatial stain profile for FOXP3 for all four fixation protocols is plotted in Fig 6c). The dynamically fixed samples again displayed a staining pattern consistent with C/H:6+1 and RT:24hr fixation. This is in marked contrast to the C/H:2+1 samples that had roughly 70% less staining at the center versus the edge of the tissue.

Fig 6. Quantitative analysis of FOXP3 staining for different fixation protocols.

Fig 6

a) Penetration depth of proper FOXP3 staining, as defined by distance into tissue where staining drops to half its edge value. b) Percent of tissue displaying proper FOXP3 staining. c) Normalized FOXP3 expression plotted versus distance into tissue. Solid lines indicate p<0.002 according to Welch’s 2-sided t-test.

Discussion

A dominant source of error in the histology laboratory is caused by improperly fixed tissues, resulting in decreased stain intensity and poor morphology [2931]. In this work, we have shown the development of a first-of-its-kind tissue fixation system capable of determining in real-time when a biospecimen has adequate formaldehyde to guarantee high-quality fixation as demonstrated by ideal and spatially uniform functional staining from downstream IHC assays. The predictive algorithm was trained on a combination of H&E-based morphology as well as characteristic diffusion curves from tonsil samples. Ultimately, our system was validated by comparing staining results from different fixation protocols. Dynamically fixed samples, with diffusion times actively controlled by our statistical model, were found to have equivalent FOXP3 and bcl-2 staining compared to the current clinical gold-standard of 24 hour room temperature fixation.

In today’s histology lab, the process of tissue fixation is largely dictated by workflow considerations. At a number of facilities, the timing of starting the tissue processor at the end of the day, to run a standard overnight protocol for the morning shift, dictate fixation times. As a result, fixation times can vary significantly in the same and certainly at different institutions. One difficulty of having varied preanalytic parameters is the inability to share data and results easily across multiple sites [2]. Clinicians would benefit greatly from data collected from standardized samples that were treated with the same fixation protocol. For instance, digital pathology algorithms can output inconsistent results when analyzing samples with improper preanalytical processing. We report more consistent staining levels with properly fixed tissues compared to poorly fixed samples for FOXP3 and bcl-2 staining (S2 Fig). Another benefit of standardizing tissue fixation is increased efficiency which would reduce the amount of costly re-work due to poor quality or lost tissues. The costs of this re-work often falls on the testing lab and could be greatly reduced with a standardized system as part of a fully documented preanalytical workflow.

We have previously reported that a novel fixation protocol, based on two temperature zones, better preserves labile biomarkers such as phospho-proteins and mRNA [48]. More rapid and efficient techniques, such as two-temperature fixation, will become necessary as the number of samples continues to increase and diagnostic assays rely on next generation biomarkers. We have described here a system to take advantage of this more efficient method of fixing tissues by standardizing formaldehyde penetration. Histology practices have been around for decades and these practices are difficult to change. The methods and instrumentation we describe take advantage of the same reagents (10% NBF) and procedures (formaldehyde crosslinking) and therefore do not alter downstream assay protocols or results. Rather, this and other more efficient methods of tissue standardization will be necessary to enable accurate preservation and quantitation of future analytes.

In this work we have tested and validated our system using FOXP3 expression in human tonsil samples, however, we believe the system will be applicable to all biomarkers and tissue types. For example, additional data relating to faithful preservation of bcl-2 with our novel fixation method is presented in Supplemental material. The dynamic fixation protocol demonstrated equivalent staining to clinical 24 hour room temperature fixation (compare S1 vs S2 Figs). The expression pattern for bcl-2 did not show a heavy dependence on fixation quality, which was expected because it is a known as a robust clinical biomarker. This result highlights that improved fixation will be particularly beneficial for labile biomarkers. Analysis of staining intensity for differentially fixed tissues is presented in S3 Fig. Additionally, we have previously generated diffusion data for 34 different tissue types and shown that each has its own characteristic diffusion rate and therefore our predictive statistical model can be applied to multiple tissue types (S3 Fig and S1 Table) [46].

This work presents a method of optimizing the infiltration of formalin into a tissue specimen. Although fixation quality is a dominant factor to determine tissue quality, multiple additional factors can influence the quality of a sample such as warm and cold ischemia time, fixation time and type, dehydration, paraffin embedding, and storage conditions. One of the next steps for this technology is to explore the use of this predictive algorithm empirically on other tissue types and biomarkers, in particular biomarkers known to be preanalytically sensitive. Future work will entail extending our current criterion, developed with tonsil tissue, to a plurality of tissue types so that a universal fixation criterion can be realized. We postulate that the current metrology can be tuned to create a generalizable model that can optimally predict when all types of tissue are appropriately fixed. We believe the histology lab of the future could employ this analytical method as part of a random-access automated processing unit that could ensure and document that individual tissue samples are optimally fixed, and truly transform tissue fixation into a science.

Supporting information

S1 Fig. Quantitative bcl-2 expression for different fixation protocols.

a) Penetration depth of proper bcl-2 staining. b) Area of proper bcl-2 staining. c) Normalized bcl-2 expression plotted versus distance into the tissue.

(TIF)

S2 Fig. Quantitative analysis of stain intensity for different fixation protocols.

a) Normalized intensity of FOXP3 staining plotted versus distance into the tissue. b) Normalized intensity of bcl-2 staining plotted versus distance into the tissue.

(TIF)

S3 Fig. Projected optimal fixation times for numerous tissue types based on the developed predictive algorithm.

(TIF)

S1 Table. Average decay constant and average predicted optimal fixation times for different tissue types.

(XLSX)

S1 Video. Real-time example of algorithm to predict optimal fixation time.

Acquisition of TOF-based diffusion curve from a 6 mm tonsil in 4% NBF with a graphical display of the developed optimal fixation prediction algorithm.

(AVI)

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Fox CH, Johnson FB, Whiting J, Roller PP. Formaldehyde fixation. J Histochem Cytochem. 1985;33(8):845–53. doi: 10.1177/33.8.3894502 [DOI] [PubMed] [Google Scholar]
  • 2.Compton CC, Robb JA, Anderson MW, Berry AB, Birdsong GG, Bloom KJ, et al. Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine. Arch Pathol Lab Med. 2019;143(11):1346–63. doi: 10.5858/arpa.2019-0009-SA [DOI] [PubMed] [Google Scholar]
  • 3.Ferris AM, Giberson RT, Sanders MA, Day JR. Advanced laboratory techniques for sample processing and immunolabeling using microwave radiation. J Neurosci Methods. 2009;182(2):157–64. doi: 10.1016/j.jneumeth.2009.06.002 [DOI] [PubMed] [Google Scholar]
  • 4.Iesurum A, Balbi T, Vasapollo D, Cicognani A, Ghimenton C. Microwave processing and ethanol-based fixation in forensic pathology. Am J Forensic Med Pathol. 2006;27(2):178–82. doi: 10.1097/01.paf.0000221050.64572.01 [DOI] [PubMed] [Google Scholar]
  • 5.Antunes L, Montagne K, Weinbreck N, Marchal L, Thiebault D, Bonnet C, et al. Possible role of tissue shrinkage in high-temperature antigen retrieval. Histopathology. 2006;48(4):471–3. doi: 10.1111/j.1365-2559.2005.02269.x [DOI] [PubMed] [Google Scholar]
  • 6.Looi LM, Loh KC. Microwave-stimulated formaldehyde fixation of experimental renal biopsy tissues: computerised morphometric analysis of distortion artefacts. Malays J Pathol. 2005;27(1):23–7. [PubMed] [Google Scholar]
  • 7.Hafajee ZA, Leong AS. Ultra-rapid microwave-stimulated tissue processing with a modified protocol incorporating microwave fixation. Pathology. 2004;36(4):325–9. doi: 10.1080/00313020410001722374 [DOI] [PubMed] [Google Scholar]
  • 8.Adams D. Microwave-assisted rapid tissue processing. Am J Clin Pathol. 2004;122(4):612–3; author reply 3–4. [PubMed] [Google Scholar]
  • 9.Morales AR, Essenfeld H, Essenfeld E, Duboue MC, Vincek V, Nadji M. Continuous-specimen-flow, high-throughput, 1-hour tissue processing. A system for rapid diagnostic tissue preparation. Arch Pathol Lab Med. 2002;126(5):583–90. doi: 10.5858/2002-126-0583-CSFHTH [DOI] [PubMed] [Google Scholar]
  • 10.Arber DA. Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers. Appl Immunohistochem Mol Morphol. 2002;10(2):183–6. doi: 10.1097/00129039-200206000-00015 [DOI] [PubMed] [Google Scholar]
  • 11.Ruijter ET, Miller GJ, Aalders TW, van de Kaa CA, Schalken JA, Debruyne FM, et al. Rapid microwave-stimulated fixation of entire prostatectomy specimens. Biomed-II MPC Study Group. J Pathol. 1997;183(3):369–75. [DOI] [PubMed] [Google Scholar]
  • 12.Boon ME. Microwave-antigen retrieval: the importance of pH of the retrieval solution for MIB-1 staining. Eur J Morphol. 1996;34(5):375–9. [DOI] [PubMed] [Google Scholar]
  • 13.Ainley CD, Ironside JW. Microwave technology in diagnostic neuropathology. J Neurosci Methods. 1994;55(2):183–90. doi: 10.1016/0165-0270(94)90210-0 [DOI] [PubMed] [Google Scholar]
  • 14.Boon ME, Marani E. The major importance of temperature data in publications concerning microwave techniques. Eur J Morphol. 1991;29(3):184–5. [PubMed] [Google Scholar]
  • 15.Kok LP, Boon ME. Physics of microwave technology in histochemistry. Histochem J. 1990;22(6–7):381–8. doi: 10.1007/BF01003174 [DOI] [PubMed] [Google Scholar]
  • 16.Leong AS. Microwave irradiation in histopathology. Pathol Annu. 1988;23 Pt 2:213–34. [PubMed] [Google Scholar]
  • 17.Boon ME, Gerrits PO, Moorlag HE, Nieuwenhuis P, Kok LP. Formaldehyde fixation and microwave irradiation. Histochem J. 1988;20(6–7):313–22. doi: 10.1007/BF01002723 [DOI] [PubMed] [Google Scholar]
  • 18.Leong AS, Duncis CG. A method of rapid fixation of large biopsy specimens using microwave irradiation. Pathology. 1986;18(2):222–5. doi: 10.3109/00313028609059463 [DOI] [PubMed] [Google Scholar]
  • 19.Kok LP, Boon ME, Ouwerkerk-Noordam E, Gerrits PO. The application of a microwave technique for the preparation of cell blocks from sputum. J Microsc. 1986;144(Pt 2):193–9. doi: 10.1111/j.1365-2818.1986.tb02799.x [DOI] [PubMed] [Google Scholar]
  • 20.Boon ME, Kok LP, Ouwerkerk-Noordam E. Microwave-stimulated diffusion for fast processing of tissue: reduced dehydrating, clearing, and impregnating times. Histopathology. 1986;10(3):303–9. doi: 10.1111/j.1365-2559.1986.tb02484.x [DOI] [PubMed] [Google Scholar]
  • 21.Leong AS, Daymon ME, Milios J. Microwave irradiation as a form of fixation for light and electron microscopy. J Pathol. 1985;146(4):313–21. doi: 10.1002/path.1711460404 [DOI] [PubMed] [Google Scholar]
  • 22.Durgun-Yucel B, Dere F, Yucel AH, Oguz O. Rapid fixation of whole organ specimens and attendant problems. Acta Med Okayama. 1992;46(2):75–81. doi: 10.18926/AMO/32649 [DOI] [PubMed] [Google Scholar]
  • 23.Dawson IM. Fixation: what should the pathologist do? Histochem J. 1972;4(4):381–5. doi: 10.1007/BF01005011 [DOI] [PubMed] [Google Scholar]
  • 24.Ericsson JL, Biberfeld P. Studies on aldehyde fixation. Fixation rates and their relation to fine structure and some histochemical reactions in liver. Lab Invest. 1967;17(3):281–98. [PubMed] [Google Scholar]
  • 25.Theiss AP, Chafin D, Bauer DR, Grogan TM, Baird GS. Immunohistochemistry of colorectal cancer biomarker phosphorylation requires controlled tissue fixation. PLoS One. 2014;9(11):e113608. doi: 10.1371/journal.pone.0113608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chafin D, Theiss A, Roberts E, Borlee G, Otter M, Baird GS. Rapid two-temperature formalin fixation. PLoS One. 2013;8(1):e54138. doi: 10.1371/journal.pone.0054138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Plebani M, Sciacovelli L, Aita A, Pelloso M, Chiozza ML. Performance criteria and quality indicators for the pre-analytical phase. Clin Chem Lab Med. 2015;53(6):943–8. doi: 10.1515/cclm-2014-1124 [DOI] [PubMed] [Google Scholar]
  • 28.Plebani M. Diagnostic Errors and Laboratory Medicine—Causes and Strategies. EJIFCC. 2015;26(1):7–14. [PMC free article] [PubMed] [Google Scholar]
  • 29.Mathews M, Newbury J, Housser EM. Shaping policy: the Canadian Cancer Society and the Hormone Receptor Testing Inquiry. Curr Oncol. 2011;18(4):174–9. doi: 10.3747/co.v18i4.910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Engel KB, Moore HM. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med. 2011;135(5):537–43. doi: 10.5858/2010-0702-RAIR.1 [DOI] [PubMed] [Google Scholar]
  • 31.De Marzo AM, Fedor HH, Gage WR, Rubin MA. Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays. Hum Pathol. 2002;33(7):756–60. doi: 10.1053/hupa.2002.126187 [DOI] [PubMed] [Google Scholar]
  • 32.Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48(5):691–8. [PubMed] [Google Scholar]
  • 33.Singhal P, Singh NN, Sreedhar G, Banerjee S, Batra M, Garg A. Evaluation of Histomorphometric Changes in Tissue Architecture in Relation to Alteration in Fixation Protocol—An Invitro Study. J Clin Diagn Res. 2016;10(8):ZC28–32. doi: 10.7860/JCDR/2016/19007.8236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Partridge SC, Mullins C. D., Kurland B. F., Allain M. D., DeMartini W. B., Eby P. R., et al. Apparent Diffusion Coefficient Values for Discriminating Benign and Malignant Breast MRI Lesions: Effects of Lesion Type and Size. American Roentgen Ray Society. 2012. [DOI] [PubMed] [Google Scholar]
  • 35.Petrasek Z, Schwille P. Precise measurement of diffusion coefficients using scanning fluorescence correlation spectroscopy. Biophys J. 2008;94(4):1437–48. doi: 10.1529/biophysj.107.108811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging. 2007;25(1):146–52. doi: 10.1002/jmri.20793 [DOI] [PubMed] [Google Scholar]
  • 37.DuMond J, and Youtz, J. P. An X‐Ray Method of Determining Rates of Diffusion in the Solid State.. 2004.
  • 38.Uhl M, Altehoefer C, Kontny U, Il’yasov K, Buchert M, Langer M. MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol. 2002;12(9):2335–8. doi: 10.1007/s00330-002-1310-9 [DOI] [PubMed] [Google Scholar]
  • 39.Helander KG. Kinetic studies of formaldehyde binding in tissue. Biotech Histochem. 1994;69(3):177–9. doi: 10.3109/10520299409106282 [DOI] [PubMed] [Google Scholar]
  • 40.Oldenburg AL, Boppart SA. Resonant acoustic spectroscopy of soft tissues using embedded magnetomotive nanotransducers and optical coherence tomography. Phys Med Biol. 2010;55(4):1189–201. doi: 10.1088/0031-9155/55/4/019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hall CS, Dent CL, Scott MJ, Wickline SA. High-frequency ultrasound detection of the temporal evolution of protein cross linking in myocardial tissue. IEEE Trans Ultrason Ferroelectr Freq Control. 2000;47(4):1051–8. doi: 10.1109/58.852089 [DOI] [PubMed] [Google Scholar]
  • 42.Bamber JC, Hill CR, King JA. Acoustic properties of normal and cancerous human liver-II. Dependence of tissue structure. Ultrasound Med Biol. 1981;7(2):135–44. doi: 10.1016/0301-5629(81)90002-8 [DOI] [PubMed] [Google Scholar]
  • 43.Bamber JC, Hill CR. Acoustic properties of normal and cancerous human liver-I. Dependence on pathological condition. Ultrasound Med Biol. 1981;7(2):121–33. doi: 10.1016/0301-5629(81)90001-6 [DOI] [PubMed] [Google Scholar]
  • 44.Bamber JC, Hill CR, King JA, Dunn F. Ultrasonic propagation through fixed and unfixed tissues. Ultrasound Med Biol. 1979;5(2):159–65. doi: 10.1016/0301-5629(79)90084-x [DOI] [PubMed] [Google Scholar]
  • 45.Bamber JC, Hill CR. Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature. Ultrasound Med Biol. 1979;5(2):149–57. doi: 10.1016/0301-5629(79)90083-8 [DOI] [PubMed] [Google Scholar]
  • 46.Bauer DR, Stevens B, Chafin D, Theiss AP, Otter M. Active monitoring of formaldehyde diffusion into histological tissues with digital acoustic interferometry. J Med Imaging (Bellingham). 2016;3(1):017002. doi: 10.1117/1.JMI.3.1.017002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lerch ML, Bauer DR, Chafin D, Theiss A, Otter M, Baird GS. Precision Medicine Starts With Preanalytics: Real-Time Assessment of Tissue Fixation Quality by Ultrasound Time-of-Flight Analysis. Appl Immunohistochem Mol Morphol. 2017;25(3):160–7. doi: 10.1097/PAI.0000000000000489 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Abbey P. Theiss, Jiang D, Bauer DR, Pedata A, Tillu D, Robida MD, et al. Increased Detection of RNA Species in Histological Tissues Using a Two-Temperature Fixation Protocol. Journal of Molecular Histology & Medical Physiology. 2017;2(2). [Google Scholar]

Decision Letter 0

Anna Sapino

13 Jul 2021

PONE-D-21-16557

Making a Science Out of Preanalytics: An Analytical Method to Determine Optimal Tissue Fixation in Real-time

PLOS ONE

Dear Dr.  Bauer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

I read with attention the referees' comments, and I think that the paper would benefit if you could test tissues of different organs and samples obtained using different sampling procedures. From the title a reader would expect molecular analyses, thus at least the analysis of DNA quality should be integrated.

==============================

Please submit your revised manuscript by July 30th If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Anna Sapino

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating in the manuscript Methods section: 'Human tonsil tissue was obtained fresh and unfixed from a local Tucson, Arizona hospital under a contractual agreement with approved protocols.'

a. Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study and confirm that your named institutional review board or ethics committee specifically approved this study. 

b. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research 

3. Thank you for stating the following in the Competing Interests section: 

"DB, TL and DC were full-time employees of Roche Tissue Diagnostics during this work. There are no products in development or marketed products to declare. Roche Tissue Diagnostics has filed patents on the TOF technology and associated algorithms." 

We note that you received funding from a commercial source: Roche Tissue Diagnostics

Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. 

Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. 

Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

6. We note that Figure(s) 4 and 5 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript presents a tool based on a statistical model to determine the quality of fixation. Although the topic is interesting I believe that the manuscript is difficult to read in the present form and some mandatory minor revisions are needed before its publication.

My concerns:

First of all the revision process is quite challenging without page and row numbers. Please, in the revised manuscript include them.

Introduction: “The most prevalent fixative is 10% neutral buffered formalin (NBF) which is an aqueous solution of formaldehyde in a buffer and has been used for over a century (Fox et al. 1985). Currently, proper fixation protocols are empirically determined by examining the histologically stained tissue for proper morphological features. The result is a mixed bag of adequate and poor morphology depending on the operator, institution, tissue type, and biomarker of interest.” In the last years tissue processing has been ameliorated by the publication of ISO standards for Specifications for pre-examination processes for formalin- fixed and paraffin-embedded (FFPE) tissue. There are three documents at present : specifically for DNA , RNA, proteins. In these it is clearly reported that although the formalin fixation duration can vary depending on the tissue type and size, for tissues pieces of 5 mm thickness fixation duration of 12-24 hours are reasonable for proper penetration and fixation. I suggest including that info in the introduction and commenting standards in the discussion.

Material and methods:

The study is based mostly on previous studies, therefore it is sometime difficult to follow. I suggest including in a supplementary file the relevant data used in this study and derived from previous ones.

Tissue acquisition and fixation: please, define the number of punches processed with the different fixation protocols. “Other punches” or “additionally biopsy punches” should be defined with numbers.

Time of Flight measurement: “Multiple TOF measurements were recorded throughout each tissue specimen and the spatially… Please, define how many measurements were recorded to produce the averaged signal.

Histology: “serial sections of each block” please define the number of sections.

Please, in a supplementary file, please provide the statistical tests used in the study.

Results:

-“Several time course experiments were performed using 6 mm cores of human tonsil tissues submerged into 4°C NBF followed by 1 hour in 45°C NBF (Lerch et al. 2017). After multiple experiments were analyzed, a minimum of 3 hours of cold NBF (C/H:3+1) was determined to produce acceptable histomorphology. Tissue morphology was improved with 5 hours in cold NBF (C/H:5+1) but further cold soak times provided no additional benefit. Multiple cores were then examined and it was confirmed that a C/H:5+1 protocol produced high-quality staining, see cumulative results in Fig 1a. “ Please provide how many cores were examined using the different fixation protocols. The abstract include some numbers that cannot be retrieved in the manuscript. A table could be useful to summarize it.

-Please, provide the number of samples monitored for 3 hours and 5 hours for determining the average slope.

-“Thus, the TOF-based diffusion metric and H&E-based stain quality were highly-correlated, indicating our diffusion monitoring system, if properly calibrated, was fundamentally capable of predicting eventual stain quality.” I cannot find any correlation, but the figure. Do you mean that a visual association between H&E and diffusion rate was made? Please, explain.

Discussion:

“In today’s histology lab, the process of tissue fixation is largely dictated by workflow considerations, rather than on scientific principles, with protocols that can vary significantly at different institutions.” Please, provide a reference for that sentence. I don’t believe that tissue fixation vary significantly. In my opinion the problem is not the mere fixation, but the tissue transport. The latter if made in formalin can have a detrimental effect in case of large surgical specimens.

“One difficulty of having multiple non-standardized procedures is the inability to share data and results easily across multiple sites.” Again, there is the need to define in the discussion “multiple non standardized procedures”.

Please, define the limitations of the study taking into account that tissue processing includes also dehydration steps and paraffin embedding. Improper dehydration can impact on tissue quality, especially in the storage. Furthermore, as limitations the entire study has been developed using tonsil tissues, although from the previous study the diffusion was available also for other tissues (supplementary figure).

Reviewer #2: The manuscript by Bauer and colleagues represents an interesting method for real-time evaluation of the tissue fixation process, using a digital acoustic interferometry algorithm that calculated the TOF differential followed by IHC digital pathology analysis on two markers. The work was performed on a single type of organ (tonsil) for a total of 87 samples in 4 different fixation methods. The analysis is based on different fixation times and temperatures, with deliberate hypo-fixation in some cases.

The real-time monitoring process allows to identify the moment in which the formalin penetration will allow to obtain the best morphological preservation result of the sample.

Both the technical and mathematical method are extremely accurate, as is the written and visual way of disseminating the results.

The English form is excellent, the statistics that are conducted in a rigorous manner.

The main problem is the structure of the experimental design, which consists of some important bugs.

1) Cases were collected from a single type of tissue. Since different organs have different characteristics and fixation times, it would be appropriate to characterize other tissues. Similarly, the type of sampling (biopsy, surgical specimen, cytology) also has different fixation characteristics. Authors should consider completing the study with a pilot project on other tumor types and sampling

2) The analyzed markers are not classical membrane proteins. In order to understand if all cell compartments can benefit from this real-time fission assessment approach, it is recommended to try other markers.

3) Molecular analysis, and therefore the use of nucleic acids in pathological units, has become routine. An evaluation involving tissue fixation for FFPE samples cannot also evaluate the quality of the DNA. It is advisable to extract and qualify at least part of the cases evaluated using, for example, the bioanalyzer

4) The style of both the manuscript and the bibliography is completely wrong, and it does not follow the style of the journal. Please change and correct.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-21-16557.docx

PLoS One. 2021 Oct 14;16(10):e0258495. doi: 10.1371/journal.pone.0258495.r002

Author response to Decision Letter 0


26 Aug 2021

Editor

I read with attention the referees' comments, and I think that the paper would benefit if you could test tissues of different organs and samples obtained using different sampling procedures. From the title a reader would expect molecular analyses, thus at least the analysis of DNA quality should be integrated.

The authors completely agree with the editor and reviewers that extending the TOF monitoring technology to different types of tissues is a meaningful extension of this work that would be critical to advancing the metrology toward clinical use. However, we have limited ability to address the editor's concern raised around testing our TOF semi-automated diffusion monitoring system with additional types of tissues as these experiments would take several years and resources beyond our current scope. Additionally, due to the COVID-19 pandemic we now have limited ability to engage academic research partners that would have access to fresh unfixed tissues from a variety of different organs. The authors would like to state that although real-time prediction of fixation was only empirically performed on tonsil tissue, we have demonstrated that the method is extendable to multiple other organs as documented in the modeling work done to optimize the predictive algorithm (Figure 3e, additional details added to manuscript) as well as by characterizing the diffusive properties of 34 organs (Supplemental Figure 3) with our TOF technology. Please see response to reviewers for additional details. We have also included this opinion in the discussion section as next critical steps and to perform this comprehensive set of studies with scientific rigor, would require significant resourcing and time. While we will look to extend the technology to other tissue types in the future, we present this work as a first critical step in demonstrating such a predictive algorithm to have substantial interest to the scientific community. Our goal is to present an exciting semi-automated system for real-time diffusion monitoring that would be possible to optimize tissue fixation for histological purposes. To clarify the scope of the project, we would be happy to more clearly define the scope of the work either in the manuscript’s text or in the title itself, or both if need be.

The editor’s and reviewer’s concern about DNA integrity of our C/H fixed tissues has been addressed in the response to the reviewer's where we document extensive unpublished data about this topic. To that point, we have internal and unpublished data that demonstrates equivalent RNA and DNA preservation with cold+hot fixation. This is not a surprising result since the fixation uses standard chemicals (10% Neutral Buffered Formalin) and standard tissue processing techniques. Nonetheless, we have previously checked for DNA integrity and mutation recognition using real time PCR.

Reviewer #1: The manuscript presents a tool based on a statistical model to determine the quality of fixation. Although the topic is interesting I believe that the manuscript is difficult to read in the present form and some mandatory minor revisions are needed before its publication.

My concerns:

First of all the revision process is quite challenging without page and row numbers. Please, in the revised manuscript include them.

Page numbers have been added to all the pages in the manuscript. We did not add row numbers as it can alter the formatting of the document and we are not aware of a robust method of adding row numbers to a Word document.

Introduction: “The most prevalent fixative is 10% neutral buffered formalin (NBF) which is an aqueous solution of formaldehyde in a buffer and has been used for over a century (Fox et al. 1985). Currently, proper fixation protocols are empirically determined by examining the histologically stained tissue for proper morphological features. The result is a mixed bag of adequate and poor morphology depending on the operator, institution, tissue type, and biomarker of interest.” In the last years tissue processing has been ameliorated by the publication of ISO standards for Specifications for pre-examination processes for formalin- fixed and paraffin-embedded (FFPE) tissue. There are three documents at present : specifically for DNA , RNA, proteins. In these it is clearly reported that although the formalin fixation duration can vary depending on the tissue type and size, for tissues pieces of 5 mm thickness fixation duration of 12-24 hours are reasonable for proper penetration and fixation. I suggest including that info in the introduction and commenting standards in the discussion.

Thank you for pointing out the standards that exist in the anatomical pathology lab. A more relevant reference has been inserted into the Introduction indicating standards for RT fixation (Practical Guide to Specimen Handling in Surgical Pathology, CAP 2020). FYI: The standards that the reviewer raises are for tissues fixed in room temperature formalin and with that protocol are absolutely correct. We have studied formalin fixation extensively and found that the bulk of the time necessary at room temperature fixation is for the crosslinking reaction. Diffusion takes place quickly but crosslinking is kinetically unfavorable and requires significant additional time. Based on studying fixation kinetics (Diffusion + Crosslinking), we use a cold procedure where the diffusion takes place rapidly without crosslinking. Then by raising the temperature, we can drive a very rapid crosslinking reaction with less spatial variability for fixation and have found superior biomarker preservation. We have previously published this Chafin D, et al. (2013) Rapid Two-Temperature Formalin Fixation. PLoS ONE 8(1): e54138. doi:10.1371/

journal.pone.0054138

Material and methods:

The study is based mostly on previous studies, therefore it is sometime difficult to follow. I suggest including in a supplementary file the relevant data used in this study and derived from previous ones.

Thank you for this suggestion, we have now included a supplemental file with the average decay constants (as calculated from previous studies) and the average predicted optimal fixation time for each organ (from the present work)

Tissue acquisition and fixation: please, define the number of punches processed with the different fixation protocols. “Other punches” or “additionally biopsy punches” should be defined with numbers. Thank you for this suggestion, we appreciate the opportunity to clarify our experiments and have revised the text to indicate how many 6 mm Punches were utilized for each tonsil organ. And clarified how those cores were utilized.

Time of Flight measurement: “Multiple TOF measurements were recorded throughout each tissue specimen and the spatially… Please, define how many measurements were recorded to produce the averaged signal. Thank you for pointing this omission out, we have added additional details to the “Time-of-Flight Measurement” section.

Histology: “serial sections of each block” please define the number of sections. Thank you for pointing this omission out, we have specified in the text that, in additional to the H&E slide, two serial sections were cut (one for FOXP3 staining and one for BCL2).

Please, in a supplementary file, please provide the statistical tests used in the study. The statistical test used in this study is a Welch's 2-sided t-test with a cutoff for statistical significance of p<0.002. This has been noted in the caption for Figure 5 as well as the Methods section under the heading “Statistical Methods”.

Results:

-“Several time course experiments were performed using 6 mm cores of human tonsil tissues submerged into 4°C NBF followed by 1 hour in 45°C NBF (Lerch et al. 2017). After multiple experiments were analyzed, a minimum of 3 hours of cold NBF (C/H:3+1) was determined to produce acceptable histomorphology. Tissue morphology was improved with 5 hours in cold NBF (C/H:5+1) but further cold soak times provided no additional benefit. Multiple cores were then examined and it was confirmed that a C/H:5+1 protocol produced high-quality staining, see cumulative results in Fig 1a. “ Please provide how many cores were examined using the different fixation protocols. The abstract includes some numbers that cannot be retrieved in the manuscript. A table could be useful to summarize it.

Thank you for this suggestion, we appreciate the opportunity to clarify how many tonsil cores were utilized in our experiments to examine tissue fixation quality and have revised the text to indicate how many 6 mm Punches were utilized.

-Please, provide the number of samples monitored for 3 hours and 5 hours for determining the average slope.

This data was provided on page 13 above Equation 1. “A total of 38 6 mm tonsil samples were measured in cold (7±0.5 ᵒC) 10% NBF. Of the 38 samples, 14 were monitored for 3 hours and the remaining 24 samples were monitored for 5 hours.” We have highlighted it in the text. Additionally, as these are important details, we have added in text to the Figure 2 legend stating the number of samples used for each respective case.

-“Thus, the TOF-based diffusion metric and H&E-based stain quality were highly-correlated, indicating our diffusion monitoring system, if properly calibrated, was fundamentally capable of predicting eventual stain quality.” I cannot find any correlation, but the figure. Do you mean that a visual association between H&E and diffusion rate was made? Please, explain.

Our explanation of the data is unclear and we thank the reviewer for pointing this out. We observed a difference in morphology on H&E stained slides that were poorly fixed with 3 hours of NBF diffusion time compared to those that were properly fixed with 5 hours of cold diffusion time. Similarly, the average normalized TOF slope after 3 hours and 5 hours of cold diffusion was statistically different. From this data we conclude that that the TOF-based diffusion metric has sufficient capability and sensitivity to discriminate between tissue samples that are poorly fixed and well fixed. We have added clarifying language to this paragraph to better explain these results and our reasoning.

Discussion:

“In today’s histology lab, the process of tissue fixation is largely dictated by workflow considerations, rather than on scientific principles, with protocols that can vary significantly at different institutions.” Please, provide a reference for that sentence. I don’t believe that tissue fixation vary significantly. In my opinion the problem is not the mere fixation, but the tissue transport. The latter if made in formalin can have a detrimental effect in case of large surgical specimens. Thank you for the opportunity to clarify the language. We have added additional references in the text as supporting evidence. FYI: In a decade of studying careful tissue collection practices, the suggestion that transport is the significant cause of variability is simplifying the situation in our humble opinion. After visiting multiple medical institutions and sites (large and small hospitals, reference labs and academic hospitals) it is clear there are multiple causes of variability. The two biggest factors that we have found are cold ischemia (the time the sample sits at RT after surgery) and under fixation caused by workflow considerations (ie. late surgeries leading to inadequate time in NBF and needing to start the processor in time for the morning shift). The former is a leading cause of biomarker change (both loss and addition) and the latter a leading cause in signal variability, mostly under fixation causing staining loss. In addition to these two significant variables, we and others have acknowledged differences in tissue handling procedures from different sites and is well known in the field as a significant challenge to overcome for the next generation of high profile biomarkers.

“One difficulty of having multiple non-standardized procedures is the inability to share data and results easily across multiple sites.” Again, there is the need to define in the discussion “multiple non standardized procedures”. Thank you for the opportunity to clarify the language. We have revised the text to include clarifying text and references.

Please, define the limitations of the study taking into account that tissue processing includes also dehydration steps and paraffin embedding. Improper dehydration can impact on tissue quality, especially in the storage. Furthermore, as limitations the entire study has been developed using tonsil tissues, although from the previous study the diffusion was available also for other tissues (supplementary figure).

As the review points out, there are limitations of the present study. We have added language to the discussion (page 27) to address this issue. While we have extensive experience with the Cold+hot fixation method and biomarker staining in many tissue types, we agree extending the TOF monitoring technology to additional types of tissue is a meaningful and logical extension, however due to the COVID-19 pandemic we have limited ability to engage academic research partners that would have access to fresh unfixed tissues from a variety of different organs. In addition to supplemental Figure 3 the reviewer referenced, the authors would like to highlight that the method is extendable to multiple other organs as documented in the modeling work done to optimize the predictive algorithm (Figure 3e). This modeling work was performed using characteristic TOF curves from 16 distinct organs types to provide a robust demonstration that the real-time prediction algorithm works on multiple types of tissues. We have added text to the caption for Figure 3 to note the number of organs used for the statistical modeling. We have added a list documenting all 16 types of tissues into the text of the manuscript (Page 20). Furthermore, for four of the organs the model was validated on healthy as well as cancerous tissue (Breast, Liver, Colon, Testicular). We have also added this detail into the manuscript on page 20. While we agree extending the technology in the future, we hope that the current work demonstrating a first of its kind capability is publishable in its current form.

Reviewer #2: The manuscript by Bauer and colleagues represents an interesting method for real-time evaluation of the tissue fixation process, using a digital acoustic interferometry algorithm that calculated the TOF differential followed by IHC digital pathology analysis on two markers. The work was performed on a single type of organ (tonsil) for a total of 87 samples in 4 different fixation methods. The analysis is based on different fixation times and temperatures, with deliberate hypo-fixation in some cases.

The real-time monitoring process allows to identify the moment in which the formalin penetration will allow to obtain the best morphological preservation result of the sample.

Both the technical and mathematical method are extremely accurate, as is the written and visual way of disseminating the results.

The English form is excellent, the statistics that are conducted in a rigorous manner.

The main problem is the structure of the experimental design, which consists of some important bugs.

1) Cases were collected from a single type of tissue. Since different organs have different characteristics and fixation times, it would be appropriate to characterize other tissues. Similarly, the type of sampling (biopsy, surgical specimen, cytology) also has different fixation characteristics. Authors should consider completing the study with a pilot project on other tumor types and sampling

The authors completely agree that extending the TOF monitoring technology to different types of tissues is a meaningful extension of this work that would be critical to advancing the metrology toward clinical use. Reviewer #1 also brought up the concern that the model was only demonstrated with one tissue type. We have added significant details to the manuscript to detail that the modeling was validated on 16 different types of organs and in 4 situations using healthy as well as cancerous tissue. Please refer to comment to reviewer #1 for additional details.

2) The analyzed markers are not classical membrane proteins. In order to understand if all cell compartments can benefit from this real-time fission assessment approach, it is recommended to try other markers. Thank you for the insightful comment regarding the use of FoxP3 and bcl-2 in our study. We agree there are only stains for two proteins in this study, we are confident that staining for proteins in general will benefit from this workflow based on significant past data. The TOF monitoring technology detailed here is merely a semi-automated method of performing Cold+Hot (C/H) fixation. In that respect, we have published work since 2013 detailing the impact of C/H on multiple proteins, tissue types and especially phosphoproteins, where the C/H technology has a clear advantage. The use of FoxP3 and bcl-2 are protein biomarkers that are particularly sensitive to inadequate fixation (which was one of the possible outcomes of our experiments). The use of FoxP3 and it’s subsequent staining (punctate cellular staining) allowed us the opportunity to develop digital algorithms to track anomalies that might be hard to pick up by the naked eye. The inclusion of bcl-2 allowed us to visually track anomalies in the staining pattern as well as digitally as this biomarker is in abundance. Finally, it was not our intent to re-publish the many 10’s of biomarkers that we have examined over the past decade but to rather focus on the ability to develop a tool that might allow more efficient and standardized fixation practices (that seems to be well received). Many of the publications are included in the bibliography and throughout the manuscript already for review.

3) Molecular analysis, and therefore the use of nucleic acids in pathological units, has become routine. An evaluation involving tissue fixation for FFPE samples cannot also evaluate the quality of the DNA. It is advisable to extract and qualify at least part of the cases evaluated using, for example, the bioanalyzer Thank you for this insightful comment regarding the status of nucleic acids in these samples. We have previously extracted nucleic acids from similar samples, derived from our cold+hot fixation method. In that study, we compared 15 samples for nucleic acid extraction (DNA), analyzed with the bioanalyzer for concentration, compared read length analysis for different sequencing coverages and conducted PCR based mutational analysis for the BRAFV600E single nucleotide change. Samples for Cold+hot were compared to standard 24 hour room temperature paired samples (samples were produced from the same original sample). In all cases the results were equivalent for extraction efficiency, read length analysis and the ability to call the single base alteration for BRAFV600E. The data remains unpublished as there is nothing remarkable about the C+W technique that confers an advantage to nucleic acid based analysis. Other than the samples can be fixed in a more efficient manner (much shorter time). It should be noted that a 3rd party provider provided all of the nucleic acid based extractions and sequencing and were blinded to the sample type. Since nucleic acids are not the focus of this manuscript or effort, this data is not published since there was nothing remarkable. These results are not unexpected since the C+W method still employs fixation with 10%NBF (ie. standard crosslinking) and routine tissue processing chemicals. Furthermore, one could imagine alternate workflows where partial samples are taken for different workflows if a particular lab preferred and there would not be the need to subject the entire sample to the workflow suggested here (future workflow considerations). However, as in our other publications, protein biomarker integrity can suffer with RT procedures.

4) The style of both the manuscript and the bibliography is completely wrong, and it does not follow the style of the journal. Please change and correct.

We are sincerely sorry for the oversight of the format of the bibliography and have corrected it to journal standards.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Anna Sapino

29 Sep 2021

Making a Science Out of Preanalytics: An Analytical Method to Determine Optimal Tissue Fixation in Real-time

PONE-D-21-16557R1

Dear Dr. Bauer,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Anna Sapino

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Anna Sapino

4 Oct 2021

PONE-D-21-16557R1

Making a Science Out of Preanalytics: An Analytical Method to Determine Optimal Tissue Fixation in Real-time

Dear Dr. Bauer:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Anna Sapino

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Quantitative bcl-2 expression for different fixation protocols.

    a) Penetration depth of proper bcl-2 staining. b) Area of proper bcl-2 staining. c) Normalized bcl-2 expression plotted versus distance into the tissue.

    (TIF)

    S2 Fig. Quantitative analysis of stain intensity for different fixation protocols.

    a) Normalized intensity of FOXP3 staining plotted versus distance into the tissue. b) Normalized intensity of bcl-2 staining plotted versus distance into the tissue.

    (TIF)

    S3 Fig. Projected optimal fixation times for numerous tissue types based on the developed predictive algorithm.

    (TIF)

    S1 Table. Average decay constant and average predicted optimal fixation times for different tissue types.

    (XLSX)

    S1 Video. Real-time example of algorithm to predict optimal fixation time.

    Acquisition of TOF-based diffusion curve from a 6 mm tonsil in 4% NBF with a graphical display of the developed optimal fixation prediction algorithm.

    (AVI)

    Attachment

    Submitted filename: PONE-D-21-16557.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES